A multicenter, randomized, double-blind trial comparing LY01011, a biosimilar, with denosumab (Xgeva®) in patients with bone metastasis from solid tumors
一项多中心、随机、双盲试验，比较生物类似药 LY01011 与地诺单抗 (Xgeva®) 在实体瘤骨转移患者中的疗效。
期刊:Journal of Bone Oncology
影响因子:3.5
doi:10.1016/j.jbo.2025.100661
Zhao, Mingchuan; Hu, Xichun; Zhuang, Pengpeng; Zeng, Aiping; Yu, Yan; Chen, Zhendong; Sun, Hongmei; Yang, Weihua; Sheng, Lili; Peng, Peijian; Wang, Jingfen; Yi, Tienan; Bi, Minghong; Shi, Huaqiu; Ni, Mingli; Dai, Xiumei; Hu, Changlu; Xu, Hongjie; Lv, Dongqing; Li, Qingshan; Lei, Kaijian; Yuan, Xia; Jiang, Ou; Wang, Xicheng; Hu, Baihui; Hou, Zhe; Su, Zhaoping; Zheng, Song; Zhou, Ming; Dou, Changlin
